3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow AZD9773: new trials by email Literature Review of AZD9773 trials Research Report on AZD9773
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock AZD9773, Placebo - Severe Sepsis, Septic Shock | Phase 2 | Completed | AstraZeneca | 300 | 2010-10-01 | 2014-10-06 |
| A Study to Assess Safety,and Tolerability of 2 Doses of AZD9773 (CytoFab™) in Japanese With Severe Sepsis/Septic Shock AZD9773, Placebo - Severe Sepsis, Septic Shock | Phase 2 | Completed | AstraZeneca | 20 | 2010-07-01 | 2014-10-06 |
| AZD9773 Dose Escalation Study AZD9773 (CytoFab), Placebo - Severe Sepsis | Phase 2 | Completed | AstraZeneca | 70 | 2008-01-01 | 2013-08-22 |
Sepsis (3) · Shock, Septic (3) · Systemic Inflammatory Response Syndrome (1)
AstraZeneca (3)
Australia (1) · Belgium (1) · Canada (1) · Czechia (1) · Finland (1) · France (1) · Japan (1) · Spain (1) · United States (1)
Wayne Dankner, MD (3) · Justin Lindemann, MD (2) · Warren Botnick, MD (2) · Gordon Bernard, MD (1) · Jiri Juchelka, MD (1) · Steven Simonson, MD (1)